Cut-price drug venture takes aim at Pfizer and Astrazeneca

Cut-price drug venture takes aim at Pfizer and Astrazeneca

Submitted by admin on July 24, 2020 - 9:27am
Source: 
EP Vantage
News Tags: 
Pfizer
AstraZeneca
EQRx
drug pricing
Ibrance
Tagrisso
Headline: 
Cut-price drug venture takes aim at Pfizer and Astrazeneca
snippet: 

EQRX has closed two early-stage licensing deals to bring in small molecules that it hopes will shake up oncology pricing.

Do Not Allow Advertisers to Use My Personal information